- Home
- EVMN vs BCYC Comparison
EVMN vs BCYC Comparison
Compare EVMN & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVMN
- BCYC
- Stock Information
- Founded
- EVMN 2020
- BCYC 2009
- Country
- EVMN United States
- BCYC United Kingdom
- Employees
- EVMN N/A
- BCYC N/A
- Industry
- EVMN Biotechnology: Pharmaceutical Preparations
- BCYC Biotechnology: Pharmaceutical Preparations
- Sector
- EVMN Health Care
- BCYC Health Care
- Exchange
- EVMN Nasdaq
- BCYC Nasdaq
- Market Cap
- EVMN 553.7M
- BCYC 565.5M
- IPO Year
- EVMN 2025
- BCYC 2019
- Fundamental
- Price
- EVMN $18.41
- BCYC $6.44
- Analyst Decision
- EVMN
- BCYC Buy
- Analyst Count
- EVMN 0
- BCYC 11
- Target Price
- EVMN N/A
- BCYC $20.73
- AVG Volume (30 Days)
- EVMN 1.4M
- BCYC 342.2K
- Earning Date
- EVMN 01-01-0001
- BCYC 10-30-2025
- Dividend Yield
- EVMN N/A
- BCYC N/A
- EPS Growth
- EVMN N/A
- BCYC N/A
- EPS
- EVMN N/A
- BCYC N/A
- Revenue
- EVMN $3,000,000.00
- BCYC $28,339,000.00
- Revenue This Year
- EVMN N/A
- BCYC N/A
- Revenue Next Year
- EVMN N/A
- BCYC N/A
- P/E Ratio
- EVMN N/A
- BCYC N/A
- Revenue Growth
- EVMN 40.00
- BCYC N/A
- 52 Week Low
- EVMN $16.70
- BCYC $6.10
- 52 Week High
- EVMN $24.03
- BCYC $25.39
- Technical
- Relative Strength Index (RSI)
- EVMN N/A
- BCYC 35.61
- Support Level
- EVMN N/A
- BCYC $6.10
- Resistance Level
- EVMN N/A
- BCYC $9.08
- Average True Range (ATR)
- EVMN 0.00
- BCYC 0.54
- MACD
- EVMN 0.00
- BCYC -0.24
- Stochastic Oscillator
- EVMN 0.00
- BCYC 9.56
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.